Looking ahead, Laxmi Dental is well-positioned with planned capex and a strategic shift toward branded products. However, the absence of long-term contracts introduces uncertainty to near-term growth prospects. At a valuation of 93 times, the valuation appears expensive. Hence, we assign a "Neutral" rating.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Deven Choksey Report
Laxmi Dental Ltd. will launch its initial public offering on January 13 and the offer closes for subscription on Jan. 15. India’s only end-to-end integrated dental product company has fixed the price band in the range of Rs 407 to 428 per share. The minimum order lot for bidding is 33.
The Rs 698.06 crore IPO consists of a fresh issue of 32 lakh shares worth Rs 138 crore and an offer-for-sale of 1.31 lakh shares totalling Rs 560.06 crore.
The allotment for Laxmi Dental IPO is expected to be finalised on Jan. 16.
The shares will be listed on both the National Stock Exchange and the BSE on Jan 20.
Object of the offer
Repayment of borrowings,
Investment in subsidiaries,
Funding Capex,
General corporate purposes.
Outlook and Valuation:
Laxmi Dental stands out as India’s only end-to-end integrated dental products company. Over the years, it has consistently expanded its production capacity and diversified its product portfolio. With increasing awareness of oral health, rising disposable incomes, and advancements in dental technologies, the demand for cosmetic dentistry procedures like teeth whitening and clear aligners is growing rapidly.
Positioned to benefit from these industry tailwinds, Laxmi Dental plans to allocate approximately Rs 700 million from IPO proceeds towards capex out of which approximately Rs 380 million would be deployed in FY26.
Historically, the company has achieved a five times asset turnover. The share of branded products in its revenue has risen significantly, from 18% in FY22 to 40% in FY24, contributing to margin expansion.
Looking ahead, Laxmi Dental is well-positioned with planned capex and a strategic shift toward branded products. However, the absence of long-term contracts introduces uncertainty to near-term growth prospects. At a valuation of 93 times, the valuation appears expensive. Hence, we assign a "Neutral" rating.
Click on the attachment to read the full IPO report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Laxmi India Finance IPO Listing: Shares Debut At 13% Discount To Issue Price

Laxmi India Finance IPO Allotment: Steps To Check Status, Latest GMP And Other Key Details


Laxmi India Finance IPO Subscribed 1.85 Times For Final Day


Laxmi Dental Gets Motilal Oswal's 'Buy' Initiation On A Strong Growth Trajectory
